Precigen (NASDAQ: PGEN) COO sells 33,772 shares in Rule 10b5-1 plan
Rhea-AI Filing Summary
PRECIGEN, INC. Chief Operating Officer Rutul R. Shah exercised fully vested stock options to acquire 33,772 common shares at $2.33 per share and, on the same date, sold 33,772 shares at $6.50 per share under a Rule 10b5-1 trading plan. After the exercise, he held 123,304 stock options.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 33,772 shares ($141K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Shah Rutul R
Role
Chief Operating Officer
Sold
33,772 shs ($220K)
Approx. gross sale proceeds
$220K
Approx. exercise cost
$79K
Approx. pre-tax spread
$141K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Option to Purchase Common Stock (Right to Buy) F2 | 33,772 | $0.00 | $0.00 |
| Exercise | Common Stock | 33,772 | $2.33 | $79K |
| Sale | Common Stock F1 | 33,772 | $6.50 | $220K |
Holdings After Transaction:
Option to Purchase Common Stock (Right to Buy) — 123,304 shares (Direct);
Common Stock — 497,751 shares (Direct)
Footnotes (2)
- F1. Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person.
- F2. The stock options are fully vested.
Key Figures
Options exercised: 33,772 options
Shares sold: 33,772 shares
Exercise price: $2.33 per share
+3 more
6 metrics
Options exercised
33,772 options
Stock options exercised at $2.33 per share on 2026-08-03
Shares sold
33,772 shares
Common stock sold at $6.50 per share on 2026-08-03 under Rule 10b5-1 plan
Exercise price
$2.33 per share
Exercise price for options to purchase common stock
Sale price
$6.50 per share
Per-share price received for sale of common stock
Options remaining
123,304 options
Derivative securities beneficially owned after reported option exercise
Option expiration
2032-02-02
Expiration date of the stock options that were exercised
Key Terms
Option to Purchase Common Stock (Right to Buy), Rule 10b5-1 plan, derivative security
3 terms
Option to Purchase Common Stock (Right to Buy) financial
"Security title: Option to Purchase Common Stock (Right to Buy)"
Rule 10b5-1 plan regulatory
"Represents shares sold pursuant to the terms of a 10b5-1 plan"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Precigen (PGEN) report for COO Rutul R. Shah?
Rutul R. Shah exercised stock options and sold Precigen shares. He exercised 33,772 options at $2.33 per share, then sold 33,772 common shares at $6.50 per share, with the sale executed under a pre-arranged Rule 10b5-1 trading plan.
At what price did Rutul R. Shah exercise his Precigen (PGEN) stock options?
He exercised stock options at an exercise price of $2.33 per share for 33,772 underlying shares. The options were fully vested at the time of exercise and are scheduled to expire on 2032-02-02 if not previously exercised or cancelled.
How many Precigen (PGEN) stock options does the COO hold after this Form 4 transaction?
After the reported option exercise, Rutul R. Shah beneficially owned 123,304 stock options. This figure reflects derivative securities remaining following the exercise of 33,772 options and is disclosed in the post-transaction holdings column for the derivative security.
What is the expiration date of the Precigen (PGEN) stock options exercised by the COO?
The exercised stock options are scheduled to expire on 2032-02-02. A footnote notes that these options were fully vested, and the Form 4 lists this expiration date for the derivative security corresponding to the 33,772 options exercised into common stock.